NCT06788132 (SBERRY) is a NA clinical trial of Cranberry products in Premature Rupture of Membranes, sponsored by Ricardo A Gutierrez Ramirez, MD, MSc, FACOG.

Who is sponsoring NCT06788132?

NCT06788132 is sponsored by Ricardo A Gutierrez Ramirez, MD, MSc, FACOG.

What drugs are being tested in NCT06788132?

Interventions in NCT06788132: Cranberry products, Placebo.

What condition does NCT06788132 study?

NCT06788132 studies Premature Rupture of Membranes, Fetal Complications.

Is NCT06788132 still recruiting?

NCT06788132 is currently completed. Last updated 8 September 2025.

Last reviewed 2025-09-08 · How we verify

NCT06788132: SBERRY

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cranberry, Hibiscus, and Vitamin C Extracts Versus Placebo in Latency of Premature Rupture of Membranes.

Completed NA Last updated 8 September 2025

What this trial tests

NA trial testing Cranberry products in Premature Rupture of Membranes in 84 participants. Completed in 31 August 2025.

Timeline

30 January 2025

Primary endpoint
31 July 2025

31 August 2025

Quick facts

Lead sponsor	Ricardo A Gutierrez Ramirez, MD, MSc, FACOG
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	84
Start date	30 January 2025
Primary completion	31 July 2025
Estimated completion	31 August 2025
Sites	1 location across Honduras

Drugs / interventions tested

Cranberry products — full drug profile →
Placebo

Conditions studied

Premature Rupture of Membranes — all drugs for Premature Rupture of Membranes →
Fetal Complications — all drugs for Fetal Complications →

Sponsor

Ricardo A Gutierrez Ramirez, MD, MSc, FACOG — full company profile →

Who can join

Adults 18 to 45, female only, with Premature Rupture of Membranes or Fetal Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective of this clinical trial is to evaluate the effect of cranberry, hibiscus and vitamin C extracts supplementation on the duration of the latency of premature rupture of membranes in pregnant women between 24 and 34 weeks with PROM compared to placebo administration through a randomized double-blind clinical trial, which will be carried out from July to December 2024 in the pathological hospitalization ward of the Hospital Materno Infantil, with a sample of 84 pregnant women, divided into 2 equal groups (A and B), a control group and a placebo group, where 1 capsule per day will be administered, containing a combination of blueberry extract 100mg equivalent 36 mg, hibiscus extract 20 mg, vitamin C 500 mg with lactobacillus 200 MU or a starch capsule for 10 days. In addition, routine complementary studies will be carried out and through descriptive statistics using Redcap for data tabulation and analysis, it will be possible to prove or reject the hypothesis that proposes that the use of cranberry, vitamin C and Hibiscus supplementation does not prolong the latency of premature rupture of membranes.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Lactobacillus, vitamin C, cranberry and hibiscus versus placebo for prolonging the latency period of premature rupture of membranes: a double-blind randomized clinical trial.
Portillo Gonzales IJ, Lobo Oliva RA, Colindres Cruz BM, Díaz Galeas LY, et al · · 2026 · PMID 41500088 · DOI 10.1016/j.ejogrb.2026.114938

Verify or expand the search:

Other recruiting trials for Premature Rupture of Membranes

Currently open trials in the same condition.

NCT07517796 — I.V Papavrine for Labor Induction in Term PROM · Phase 4 · recruiting

Other Ricardo A Gutierrez Ramirez, MD, MSc, FACOG trials

Trials by the same sponsor.

NCT07401147 — Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Management During Labor. · NA · recruiting
NCT06811584 — Peanut Ball in Labor to Reduce Anxiety and Pain · NA · completed
NCT06809985 — Latent Phase Membrane Stripping for Caesarean Section Reduction · NA · completed
NCT06784024 — Topical Lidocaine vs. Traditional Management in Manual Vacuum Aspiration Pain Management. · NA · completed
NCT06760026 — Cosmetic Results With Tissue Adhesive vs. Subdermal Sutures in Cesarean Section · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06788132 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ricardo A Gutierrez Ramirez, MD, MSc, FACOG
Last refreshed: 8 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06788132.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing